Company profile

Fauna Bio company profile

Fauna Bio is developing new ways to treat human diseases, such as heart disease and neurodegenerative disease, by adopting mechanisms animals have developed for traits such as hibernation and deep-diving. Founded by three scientists who have intimate knowledge of the best science and resources from the field of non-model organisms, Fauna Bio leverages data from hundreds of species in order to help develop pre-clinical and early clinical testing for new therapeutics targeting human diseases.

Business identity

Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2018-01-01

Headquarters

Headquarters
Berkeley, California, United States
Postal code
94710
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
4
Total equity funding
$13.1M
Last funding
Seed / $9M / 2021-09-21
Last equity funding
Seed / $9M
Investors
13
Lead investors
4
Founders
3
Articles
29

Founders and investors

Founders

Ashley ZehnderKatie GrabekLinda Goodman

Lead investors

Lifeforce CapitalNational Human Genome Research InstituteNational Institutes of HealthTrue Ventures

Investors

GRIDS CapitalLifeforce CapitalNational Institutes of HealthThe Longevity FundTrue Ventures

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.